CDH2 and lung carcinoma: Our results showed that, in 34 cases of lung cancer, the CDH1 demonstrated lower expression, while N-cadherin and vimentin had higher levels of expression in tumor tissues, which were significantly different from those in the corresponding noncancerous tissues (n = 34, Figure 6(a)).